Share-based Payment Arrangement, Expense of Dolby Laboratories, Inc. from 25 Jun 2010 to 26 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Dolby Laboratories, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 25 Jun 2010 to 26 Sep 2025.
  • Dolby Laboratories, Inc. Share-based Payment Arrangement, Expense for the quarter ending 26 Sep 2025 was $31,052,000, a 4.6% increase year-over-year.
  • Dolby Laboratories, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 26 Sep 2025 was $128,514,000, a 7.3% increase year-over-year.
  • Dolby Laboratories, Inc. annual Share-based Payment Arrangement, Expense for 2025 was $128,514,000, a 7.3% increase from 2024.
  • Dolby Laboratories, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $119,825,000, a 1.1% increase from 2023.
  • Dolby Laboratories, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $118,486,000, a 3.1% increase from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Dolby Laboratories, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $128,514,000 $31,052,000 +$1,373,000 +4.6% 28 Jun 2025 26 Sep 2025 10-K 18 Nov 2025 2025 FY
Q2 2025 $127,141,000 $30,728,000 +$1,391,000 +4.7% 29 Mar 2025 27 Jun 2025 10-Q 31 Jul 2025 2025 Q3
Q1 2025 $125,750,000 $30,664,000 +$1,749,000 +6% 28 Dec 2024 28 Mar 2025 10-Q 01 May 2025 2025 Q2
Q4 2024 $124,001,000 $36,070,000 +$4,176,000 +13% 28 Sep 2024 27 Dec 2024 10-Q 30 Jan 2025 2025 Q1
Q3 2024 $119,825,000 $29,679,000 +$1,484,000 +5.3% 29 Jun 2024 27 Sep 2024 10-K 18 Nov 2025 2025 FY
Q2 2024 $118,341,000 $29,337,000 +$113,000 +0.39% 30 Mar 2024 28 Jun 2024 10-Q 31 Jul 2025 2025 Q3
Q1 2024 $118,228,000 $28,915,000 -$912,000 -3.1% 30 Dec 2023 29 Mar 2024 10-Q 01 May 2025 2025 Q2
Q4 2023 $119,140,000 $31,894,000 +$654,000 +2.1% 30 Sep 2023 29 Dec 2023 10-Q 30 Jan 2025 2025 Q1
Q3 2023 $118,486,000 $28,195,000 +$1,233,000 +4.6% 01 Jul 2023 29 Sep 2023 10-K 18 Nov 2025 2025 FY
Q2 2023 $117,253,000 $29,224,000 +$1,616,000 +5.9% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q3
Q1 2023 $115,637,000 $29,827,000 +$2,128,000 +7.7% 31 Dec 2022 31 Mar 2023 10-Q 02 May 2024 2024 Q2
Q4 2022 $113,509,000 $31,240,000 -$1,416,000 -4.3% 01 Oct 2022 30 Dec 2022 10-Q 02 Feb 2024 2024 Q1
Q3 2022 $114,925,000 $26,962,000 +$2,826,000 +12% 02 Jul 2022 30 Sep 2022 10-K 19 Nov 2024 2024 FY
Q2 2022 $112,099,000 $27,608,000 +$2,772,000 +11% 02 Apr 2022 01 Jul 2022 10-Q 03 Aug 2023 2023 Q3
Q1 2022 $109,327,000 $27,699,000 +$3,286,000 +13% 01 Jan 2022 01 Apr 2022 10-Q 05 May 2023 2023 Q2
Q4 2021 $106,041,000 $32,656,000 +$6,343,000 +24% 25 Sep 2021 31 Dec 2021 10-Q 02 Feb 2023 2023 Q1
Q3 2021 $99,698,000 $24,136,000 +$2,358,000 +11% 26 Jun 2021 24 Sep 2021 10-K 17 Nov 2023 2023 FY
Q2 2021 $97,340,000 $24,836,000 +$3,551,000 +17% 27 Mar 2021 25 Jun 2021 10-Q 09 Aug 2022 2022 Q3
Q1 2021 $93,789,000 $24,413,000 +$3,462,000 +17% 26 Dec 2020 26 Mar 2021 10-Q 05 May 2022 2022 Q2
Q4 2020 $90,327,000 $26,313,000 +$3,699,000 +16% 26 Sep 2020 25 Dec 2020 10-Q 04 Feb 2022 2022 Q1
Q3 2020 $86,628,000 $21,778,000 +$4,778,000 +28% 27 Jun 2020 25 Sep 2020 10-K 18 Nov 2022 2022 FY
Q2 2020 $81,850,000 $21,285,000 +$2,422,000 +13% 28 Mar 2020 26 Jun 2020 10-Q 29 Jul 2021 2021 Q3
Q1 2020 $79,428,000 $20,951,000 +$1,716,000 +8.9% 28 Dec 2019 27 Mar 2020 10-Q 04 May 2021 2021 Q2
Q4 2019 $77,712,000 $22,614,000 +$1,132,000 +5.3% 28 Sep 2019 27 Dec 2019 10-Q 29 Jan 2021 2021 Q1
Q3 2019 $76,580,000 $17,000,000 -$773,000 -4.3% 29 Jun 2019 27 Sep 2019 10-K 17 Nov 2021 2021 FY
Q2 2019 $77,353,000 $18,863,000 +$1,762,000 +10% 30 Mar 2019 28 Jun 2019 10-Q 03 Aug 2020 2020 Q3
Q1 2019 $75,591,000 $19,235,000 +$1,544,000 +8.7% 29 Dec 2018 29 Mar 2019 10-Q 04 May 2020 2020 Q2
Q4 2018 $74,047,000 $21,482,000 +$2,798,000 +15% 29 Sep 2018 28 Dec 2018 10-Q 29 Jan 2020 2020 Q1
Q3 2018 $71,249,000 $17,773,000 +$1,370,000 +8.4% 30 Jun 2018 28 Sep 2018 10-K 16 Nov 2020 2020 FY
Q2 2018 $69,879,000 $17,101,000 +$1,359,000 +8.6% 31 Mar 2018 29 Jun 2018 10-Q 02 Aug 2019 2019 Q3
Q1 2018 $68,520,000 $17,691,000 +$1,708,000 +11% 30 Dec 2017 30 Mar 2018 10-Q 08 May 2019 2019 Q2
Q4 2017 $66,812,000 $18,684,000 +$1,469,000 +8.5% 30 Sep 2017 29 Dec 2017 10-Q 01 Feb 2019 2019 Q1
Q3 2017 $65,343,000 $16,403,000 +$891,000 +5.7% 01 Jul 2017 29 Sep 2017 10-K 25 Nov 2019 2019 FY
Q2 2017 $64,452,000 $15,742,000 -$265,000 -1.7% 01 Apr 2017 30 Jun 2017 10-Q 01 Aug 2018 2018 Q3
Q1 2017 $64,717,000 $15,983,000 -$103,000 -0.64% 31 Dec 2016 31 Mar 2017 10-Q 02 May 2018 2018 Q2
Q4 2016 $64,820,000 $17,215,000 -$2,165,000 -11% 01 Oct 2016 30 Dec 2016 10-Q 31 Jan 2018 2018 Q1
Q3 2016 $66,985,000 $15,512,000 -$735,000 -4.5% 02 Jul 2016 30 Sep 2016 10-K 15 Nov 2018 2018 FY
Q2 2016 $67,720,000 $16,007,000 -$306,000 -1.9% 02 Apr 2016 01 Jul 2016 10-Q 03 Aug 2017 2017 Q3
Q1 2016 $68,026,000 $16,086,000 -$581,000 -3.5% 02 Jan 2016 01 Apr 2016 10-Q 03 May 2017 2017 Q2
Q4 2015 $68,607,000 $19,380,000 +$1,538,000 +8.6% 26 Sep 2015 01 Jan 2016 10-Q 02 Feb 2017 2017 Q1
Q3 2015 $67,069,000 $16,247,000 -$660,000 -3.9% 27 Jun 2015 25 Sep 2015 10-K 16 Nov 2017 2017 FY
Q2 2015 $67,729,000 $16,313,000 +$347,000 +2.2% 28 Mar 2015 26 Jun 2015 10-Q 02 Aug 2016 2016 Q3
Q1 2015 $67,382,000 $16,667,000 -$1,086,000 -6.1% 27 Dec 2014 27 Mar 2015 10-Q 04 May 2016 2016 Q2
Q4 2014 $68,468,000 $17,842,000 +$2,788,000 +19% 27 Sep 2014 26 Dec 2014 10-Q 05 Feb 2016 2016 Q1
Q3 2014 $65,680,000 $16,907,000 +$2,511,000 +17% 28 Jun 2014 26 Sep 2014 10-K 18 Nov 2016 2016 FY
Q2 2014 $63,169,000 $15,966,000 -$1,317,000 -7.6% 29 Mar 2014 27 Jun 2014 10-Q 31 Jul 2015 2015 Q3
Q1 2014 $64,486,000 $17,753,000 +$2,808,000 +19% 28 Dec 2013 28 Mar 2014 10-Q 06 May 2015 2015 Q2
Q4 2013 $61,678,000 $15,054,000 -$2,650,000 -15% 28 Sep 2013 27 Dec 2013 10-Q 30 Jan 2015 2015 Q1
Q3 2013 $64,328,000 $14,396,000 29 Jun 2013 27 Sep 2013 10-K 24 Nov 2015 2015 FY
Q2 2013 $17,283,000 30 Mar 2013 28 Jun 2013 10-Q 30 Jul 2014 2014 Q3
Q1 2013 $14,945,000 29 Dec 2012 29 Mar 2013 10-Q 30 Apr 2014 2014 Q2
Q4 2012 $17,704,000 29 Sep 2012 28 Dec 2012 10-Q 29 Jan 2014 2014 Q1
Q2 2011 $10,916,000 +$2,772,000 +34% 02 Apr 2011 01 Jul 2011 10-Q 04 Aug 2011 2011 Q3
Q2 2010 $8,144,000 27 Mar 2010 25 Jun 2010 10-Q 04 Aug 2011 2011 Q3

Dolby Laboratories, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $128,514,000 +$8,689,000 +7.3% 28 Sep 2024 26 Sep 2025 10-K 18 Nov 2025 2025 FY
2024 $119,825,000 +$1,339,000 +1.1% 30 Sep 2023 27 Sep 2024 10-K 18 Nov 2025 2025 FY
2023 $118,486,000 +$3,561,000 +3.1% 01 Oct 2022 29 Sep 2023 10-K 18 Nov 2025 2025 FY
2022 $114,925,000 +$15,227,000 +15% 25 Sep 2021 30 Sep 2022 10-K 19 Nov 2024 2024 FY
2021 $99,698,000 +$13,070,000 +15% 26 Sep 2020 24 Sep 2021 10-K 17 Nov 2023 2023 FY
2020 $86,628,000 +$10,048,000 +13% 28 Sep 2019 25 Sep 2020 10-K 18 Nov 2022 2022 FY
2019 $76,580,000 +$5,331,000 +7.5% 29 Sep 2018 27 Sep 2019 10-K 17 Nov 2021 2021 FY
2018 $71,249,000 +$5,906,000 +9% 30 Sep 2017 28 Sep 2018 10-K 16 Nov 2020 2020 FY
2017 $65,343,000 -$1,642,000 -2.5% 01 Oct 2016 29 Sep 2017 10-K 25 Nov 2019 2019 FY
2016 $66,985,000 -$84,000 -0.12% 26 Sep 2015 30 Sep 2016 10-K 15 Nov 2018 2018 FY
2015 $67,069,000 +$1,389,000 +2.1% 27 Sep 2014 25 Sep 2015 10-K 16 Nov 2017 2017 FY
2014 $65,680,000 +$1,352,000 +2.1% 28 Sep 2013 26 Sep 2014 10-K 18 Nov 2016 2016 FY
2013 $64,328,000 +$16,747,000 +35% 29 Sep 2012 27 Sep 2013 10-K 24 Nov 2015 2015 FY
2012 $47,581,000 +$3,916,000 +9% 01 Oct 2011 28 Sep 2012 10-K 18 Nov 2014 2014 FY
2011 $43,665,000 +$14,850,000 +52% 25 Sep 2010 30 Sep 2011 10-K 15 Nov 2013 2013 FY
2010 $28,815,000 26 Sep 2009 24 Sep 2010 10-K 15 Nov 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.